Tivic Health’s CEO, Jennifer Ernst, to Speak at Fifth Bioelectronic Medicine Summit - Bioelectronic Medicine: Today’s Tools, Tomorrow’s Therapies
October 06 2022 - 10:00AM
Business Wire
Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase
health technology company that develops and commercializes
bioelectronic medicine, today announced that the company’s CEO will
present at Fifth Bioelectronic Medicine Summit – Bioelectronic
Medicine: Today’s Tools, Tomorrow’s Therapies organized by the
Feinstein Institutes for Medical Research and the Columbia
University School of Engineering.
In Session 7 of the event, Jennifer Ernst will sit alongside
other panelists and discuss Neurotech – the journey from bench to
bedside. The session will discuss how, when, and where
neurotechnology makes its way through commercialization.
WHO:
Jennifer Ernst, CEO, Tivic Health
WHAT:
Fifth Bioelectronic Medicine Summit
WHERE:
Garden City, NY
WHEN:
October 11-12, 2022
About the Conference
Bioelectronic medicine is an emerging field at the convergence
of molecular medicine, neuroscience and technology with the aim of
developing novel diagnostic and therapeutic approaches. This
meeting will call international attention to bioelectronic medicine
as the platform for new developments in healthcare, technology, and
science. Leaders in bioelectronic medicine will discuss current
progress, challenges, and future developments.
About Tivic Health
Tivic Health Systems, Inc. is a commercial-phase health
technology company delivering non-invasive bioelectronic treatments
that provide consumers a choice in the treatment of inflammation
and certain other related conditions. For more information visit
https://tivichealth.com @TivicHealth.
Forward-Looking Statements
This press release may contain “forward-looking statements” that
are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press
release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of
words such as “anticipate,” “believe,” “contemplate,” “could,”
“estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,”
“potential,” “predict,” “project,” “target,” “aim,” “should,”
“will” “would,” or the negative of these words or other similar
expressions, although not all forward-looking statements contain
these words. Forward-looking statements are based on Tivic Health
Systems, Inc.’s current expectations and are subject to inherent
uncertainties, risks, and assumptions that are difficult to
predict. Further, certain forward-looking statements are based on
assumptions as to future events that may not prove to be accurate.
Additional information concerning Tivic Health and its business,
including a discussion of factors that could materially affect the
company operating results, is contained in the company’s Annual
Report on Form 10-K for the year ended December 31, 2021, filed
with the Securities and Exchange Commission on March 31, 2022,
under the heading “Risk Factors,” as well as the company’s
subsequent filings with the Securities and Exchange Commission.
Forward-looking statements contained in this press release are made
as of this date, and Tivic Health Systems, Inc. undertakes no duty
to update such information except as required by applicable
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221006005199/en/
Investor Contact: Hanover International, Inc.
ir@tivichealth.com
Media Contact: Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com 617-723-4004
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tivic Health Systems (NASDAQ:TIVC)
Historical Stock Chart
From Apr 2023 to Apr 2024